Biotech Co. Investors Clash Over 'Self-Dealing' Claim
Attorneys for a biopharmaceutical and technology company stockholder and a group of venture investors sharply disagreed Tuesday over whether a financing deal was a lifeline for a struggling company or a...To view the full article, register now.
Already a subscriber? Click here to view full article